Thyroid Assist

– A novel decision support aid tool (DST) for optimal levothyroxine dosage after thyroidectomy About the technology Levothyroxine is a necessary synthetic hormone after removal of the thyroid gland, or in patients with an underactive thyroid gland. The optimal dosage varies between individuals, making several rounds of dose adjustments required. Due to long half-life of […]

Nanospacer

– Bringing nanofluidic technology to the people About the technology The Nanospacer is a specially designed microscope coverslip that allows nanoscale particle characterization. Nanofluidic technology, including analysis of proteins and binding events on a single-molecule level, will open doors to the next generation of nanomedicines, nanoparticles and nanomachinery. Resources Research Council Norway commercialization grant Patent […]

Single-objective light-sheet imaging system (SOLIS)

Instant volume microscopy The SOLIS Microscope A new type of fluorescence microscope that combines the best aspects of confocal with light-sheet microscopy. SOLIS efficiently removes parasitic light from out-of-focus planes that would bleed through between adjacent focal planes and degrade image contrast. SOLIS is posed to fill this technology gap between methods that offer the […]

Spermotile – A sophisticated tool for improved fertilization success rate

Sperm filtration for improved success rate of assisted reproduction technology About the technology With current automated or manual IVF methods focusing on motility, the chance of identifying a sperm for fertilization is high, but the likelihood of the selected sperm being the best is small. This means an inaccurate quality analysis that takes a toll […]

Predicting relapse in Ulcerative Colitis patients

– A novel biomarker with the potential to improve the lives of millions of UC patients world-wide About the technology Ulcerative Colitis is a chronic autoimmune disorder of the colon characterized by alternating periods of remission and relapse. Disease flares occur in a random way and are currently unpredictable. Our novel prognostic biomarker can identify […]

Tau-on-Chip: nanofluidic amyloid aggregation within seconds

About the technology On-demand production of protein aggregates: We produce oligomers and fibrils within seconds in a nanofluidic environment. This has potential for high throughput screening of drug candidates, automated in-vitro assays, and binding assays with single molecule sensitivity. Areas of application We envisage producing the nanofluidic Tau-on- Chip devices for use in drug development, […]

MicroRNAs for reduced bleeding risk in Venous thromboembolism patients

– MicroRNAs for risk assessment and treatment of venous thromboembolism The challenge Venous thromboembolism (VTE) is a highly prevalent disease, affecting around 1.1 million individuals in Europe each year, with 540,000 associated deaths. No modifiable risk-factors have been identified yet. The current anti-coagulant treatment is associated with serious bleeding risks. We therefore need to find […]